Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kees Hendricksen

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
BJU International|September 24, 2017
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma CollaborationAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
European Urology|February 6, 2008
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancerKees Hendricksen, Wim P J Witjes, Jan G Idema, et al.
Scandinavian Journal of Urology|December 12, 2018
Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinomaTeele Kuusk, Roderick De Bruijn, Oscar R Brouwer, et al.
European Urology Open Science|April 27, 2023
Ileal Conduit Versus Orthotopic Neobladder Urinary Diversion in Robot-assisted Radical Cystectomy: Results from a Multi-institutional SeriesStefano Tappero, Paolo Dell'Oglio, Maria Angela Cerruto, et al.
EJNMMI Research|December 5, 2018
An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumorsTeele Kuusk, Maarten L Donswijk, Renato A Valdés Olmos, et al.
Urologic Oncology|March 7, 2018
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancerNicolas von Landenberg, Atiqullah Aziz, Friedrich C von Rundstedt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2019
Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancerCharlotte S Voskuilen, Judith Bosschieter, Erik van Werkhoven, et al.
International Journal of Cancer|May 23, 2022
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancerSarah M H Einerhand, Nick van Dijk, Jeroen van Dorp, et al.
Clinical Genitourinary Cancer|October 13, 2020
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC)Beat Foerster, Mohammad Abufaraj, Andrea Mari, et al.
Urologic Oncology|August 3, 2020
Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on sizeKarl H Tully, Marco Moschini, Friedrich-Carl E von Rundstedt, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
BJU International|September 24, 2017
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma CollaborationAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
European Urology|February 6, 2008
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancerKees Hendricksen, Wim P J Witjes, Jan G Idema, et al.
Scandinavian Journal of Urology|December 12, 2018
Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinomaTeele Kuusk, Roderick De Bruijn, Oscar R Brouwer, et al.
European Urology Open Science|April 27, 2023
Ileal Conduit Versus Orthotopic Neobladder Urinary Diversion in Robot-assisted Radical Cystectomy: Results from a Multi-institutional SeriesStefano Tappero, Paolo Dell'Oglio, Maria Angela Cerruto, et al.
EJNMMI Research|December 5, 2018
An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumorsTeele Kuusk, Maarten L Donswijk, Renato A Valdés Olmos, et al.
Urologic Oncology|March 7, 2018
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancerNicolas von Landenberg, Atiqullah Aziz, Friedrich C von Rundstedt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2019
Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancerCharlotte S Voskuilen, Judith Bosschieter, Erik van Werkhoven, et al.
International Journal of Cancer|May 23, 2022
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancerSarah M H Einerhand, Nick van Dijk, Jeroen van Dorp, et al.
Clinical Genitourinary Cancer|October 13, 2020
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC)Beat Foerster, Mohammad Abufaraj, Andrea Mari, et al.
Urologic Oncology|August 3, 2020
Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on sizeKarl H Tully, Marco Moschini, Friedrich-Carl E von Rundstedt, et al.
Pageof 10